Table 2.

Clinical outcomes of the studies depicted in Table 1.

Authors	SBRT Dose	Median Follow-Up [Months]	Local Control at 2 Years	Overall Survival at 2 Years	Toxicity (Grade 3+)
Kimura et al. [11]	40 Gy/5 fr	20.8	90%	84%	11%
Yoon et al. [12]	45 Gy/3 fr	47.8	100%	96%	4%
Durand–Labrunie et al. [13]	45 Gy/3 fr	48	94%	69%	31%
Jang et al. [14]	45–60 Gy/3 fr	41	97%	84%	3% (1 year)
Park et al. [15]	30–60 Gy/3 fr	38.2	91.3% (5 years)	44.9% (5 years)	2.8%
Kim et al. [16]	36–60 Gy/4 fr	27	25–94%	81.3%	28%
Takeda et al. [17]	35–40 Gy/5 fr	41.7	96.3% (3 years)	66.7% (3 years)	8.9%
Lasley et al. [18]	48 Gy/3 fr (CP-A), 40 Gy/3 fr (CP-B)	33.3 (CP-A), 46.3 (CP-B)	91% (CP-A), 82% (CP-B)	72% (CP-A), 32.7% (CP-B)	11% (CP-A), 38% (CP-B)
Bujold et al. [19]	24–56 Gy/6 fr	31.4	87% (1 year)	MST 17 months	10%
Kang et al. [20]	42–60 Gy/3 fr	17	94.6%	68.7%	15%

Abbreviations: fr = fraction, CP = Child–Pugh, MST = median survival time.